ArticleCancer letters2021

CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma.

Stephen T Muth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.